Targeted Endoradiotherapy with Lu<sub>2</sub>O<sub>3</sub>-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image.

Luna-Gutiérrez, Myrna; Ocampo-García, Blanca; Jiménez-Mancilla, Nallely; Ancira-Cortez, Alejandra; Trujillo-Benítez, Diana; Hernández-Jiménez, Tania; Ramírez-Nava, Gerardo; Hernández-Ramírez, Rodrigo; Santos-Cuevas, Clara; Ferro-Flores, Guillermina

Targeted Endoradiotherapy with Lu₂O₃-iPSMA/-iFAP Nanoparticles Activated by Neutron Irradiation: Preclinical Evaluation and First Patient Image.

Luna-Gutiérrez, Myrna; Ocampo-García, Blanca; Jiménez-Mancilla, Nallely; Ancira-Cortez, Alejandra; Trujillo-Benítez, Diana; Hernández-Jiménez, Tania; Ramírez-Nava, Gerardo; Hernández-Ramírez, Rodrigo; Santos-Cuevas, Clara; Ferro-Flores, Guillermina.

Afiliação

Luna-Gutiérrez M; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Ocampo-García B; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Jiménez-Mancilla N; Cátedras CONACyT, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Ancira-Cortez A; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Trujillo-Benítez D; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Hernández-Jiménez T; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Ramírez-Nava G; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Hernández-Ramírez R; Nuclear Medicine Department, Hospital Médica Sur, Mexico City 14080, Mexico.
Santos-Cuevas C; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.
Ferro-Flores G; Department of Radioactive Materials, Instituto Nacional de Investigaciones Nucleares, Ocoyoacac 52750, Mexico.

Pharmaceutics ; 14(4)2022 Mar 27.

Article em En | MEDLINE | ID: mdl-35456554

Palavras-chave

fibroblast activation protein inhibitor; lutetium oxide nanoparticles; lutetium-177; prostate-specific membrane antigen inhibitor

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Guideline Idioma: En Revista: Pharmaceutics Ano de publicação: 2022 Tipo de documento: Article País de afiliação: México

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google